Hiroshi Hashizume Selected Research

Hypesthesia (Numbness)

2/2007

Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Hashizume Research Topics

Disease

10	Pain (Aches) 12/2021 - 08/2000
8	Spinal Stenosis (Stenosis, Spinal) 11/2021 - 09/2013
4	Low Back Pain (Lumbago) 11/2021 - 02/2007
4	Spondylolisthesis 01/2021 - 01/2002
4	Hyperalgesia 02/2007 - 08/2000
3	Congenital Abnormalities (Deformity) 01/2022 - 05/2017
3	Spinal Cord Diseases 12/2021 - 12/2015
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 06/2013
3	Sciatica (Sciatic Neuralgia) 01/2020 - 08/2000
2	Lordosis 12/2021 - 10/2017
2	Pathologic Constriction (Stenosis) 08/2020 - 07/2012
2	Scoliosis 05/2017 - 09/2013
2	Radiculopathy (Radiculopathy, Cervical) 04/2012 - 08/2000
2	Intervertebral Disc Displacement (Herniated Disc) 02/2007 - 08/2000
2	Asthma (Bronchial Asthma) 06/2003 - 06/2003
2	Conjunctivitis 06/2003 - 06/2003
1	Kyphosis 01/2022
1	Femoracetabular Impingement 01/2021
1	Hematoma 01/2021
1	Hemorrhage 01/2021
1	Pseudarthrosis (Pseudoarthrosis) 08/2020
1	Compression Fractures (Compression Fracture) 10/2018
1	Osteoarthritis 03/2018
1	Osteoporosis 03/2018
1	Rheumatoid Arthritis 03/2018
1	Back Pain (Backache) 01/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2015
1	Mood Disorders (Mood Disorder) 11/2013
1	Spinal Diseases (Disease, Spinal) 09/2013
1	Spinal Cord Compression 05/2009
1	Hypesthesia (Numbness) 02/2007
1	Ganglion Cysts (Ganglion) 02/2007
1	Allergic Rhinitis 06/2003

Drug/Important Bio-Agent (IBA)

3	Prostaglandins DIBA 01/2021 - 06/2003
2	Ringer's LactateIBA 01/2021 - 01/2019
2	Plasma GasesIBA 01/2019 - 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2021
1	GelatinIBA 01/2021
1	SolutionsIBA 01/2021
1	Sodium Lactate FDA LinkGeneric 01/2021
1	Thrombin FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	AntioxidantsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	AutoantibodiesIBA 03/2018
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 04/2015
1	Silk FDA Link 04/2012
1	Hydroxyindoleacetic AcidIBA 02/2007
1	Serotonin (5 Hydroxytryptamine)IBA 02/2007
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2007
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 02/2007
1	AcidsIBA 02/2007
1	sarpogrelateIBA 02/2007
1	Bone Morphogenetic Protein 7IBA 09/2005
1	salicylhydroxamic acid (SHAM)IBA 09/2005
1	bicyclo(2.2.1)hepteneIBA 06/2003
1	Anti-Allergic Agents (Antiallergic Agents)IBA 06/2003
1	ProstaglandinsIBA 06/2003
1	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 03/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2002
1	Immunologic Factors (Immunomodulators)IBA 08/2000
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2000
1	CytokinesIBA 08/2000
1	fluoresceinated methotrexate (FMTX)IBA 08/2000
1	Methotrexate (Mexate)FDA LinkGeneric 08/2000

Therapy/Procedure

13	Decompression 12/2021 - 01/2002
6	Laminectomy 12/2021 - 12/2013
5	Spinal Fusion (Spondylosyndesis) 01/2022 - 01/2002
4	Laminoplasty 12/2021 - 05/2009
3	Therapeutics 01/2019 - 06/2013
2	Pedicle Screws 01/2022 - 01/2021
2	Endoscopes 11/2021 - 12/2013
2	Conservative Treatment 10/2018 - 10/2014
1	Kyphoplasty 10/2018
1	Minimally Invasive Surgical Procedures 07/2012
1	Aftercare (After-Treatment) 02/2007
1	Epidural Injections 03/2002